Composition of stimulating immunity comprising Lactobacillus rhamnosus LM1019 and starter strains

A pharmaceutical composition for preventing or treating immune-related diseases, comprising:

• a mixed strain of Lactobacillus rhamnosus LM1019 deposited under accession number KCCM12308P and starter strains, or a culture fluid or extracts of the mixed strain as an active ingredient,
• wherein the immune-related diseases include at least one selected from the group consisting of tuberculosis, pneumonia, peritonitis, urinary tract infection, meningitis, myopericarditis, encephalitis, measles, hepatitis, sepsis, bubonic plague, leprosy, syphilis, tetanus, anthrax, actinomycosis, botulism, Clostridium difficile-induced colitis, food poisoning, gas gangrene, tetanus, brucellosis, cholera, Legionnaires' disease, pertussis, bacillary dysentery, tularemia, typhoid fever, smallpox, chickenpox, shingles, COVID-19, SARS, MERS, dengue, yellow fever, Zika virus infection, Ebola virus disease, influenza, cold, avian influenza, hand-foot-mouth disease, acquired immunodeficiency syndrome (AIDS), and malaria;
• and
• the starter strains consist of Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus acidophilus, and Bifidobacterium lactis.